Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Kleinzelliges Bronchialkarzinom

  • Chapter
Kompendium Internistische Onkologie

Zusammenfassung

Häufigkeit: 3–4% aller malignen Tumoren; 15–25% aller Bronchialkarzinome.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Aisner J, Whitacre M, Echo DA van, Fuks JZ (1984) Cyclophosphamide, doxorubicin and etoposide (CAE) for the treatment of small cell lung cancer. In: Issel BF, Muggia FM, Carter SK (eds) Etoposide (VP-16). Current status and new developments. Academic Press, New York, pp 171–182

    Google Scholar 

  • Alba E, Breton JJ, Alonso L, Paredes G, Belon J, Ballesteros P (1992) Alternating chemotherapy for small-cell lung cancer. A twelve-week schedule of six drugs. Ann Oncol 3: 31–35

    Google Scholar 

  • Allan SG, Gregor A, Cornbleet MA, Leonard RCF, Smyth JF, Grant IWB, Crompton GK (1984) Phase II trial of vindesine and VP 16 in the palliation of poor-prognosis patients and elderly patients with small cell lung cancer. Cancer Chemother Pharmacol 13: 106–108

    Article  PubMed  CAS  Google Scholar 

  • Ambrosone CB, Rao U, Michalek AM, Cummings KM, Mettlin CJ (1993) Lung cancer histologic types and family history of cancer. Analysis of histologic subtypes of 872 patients with primary lung cancer. Cancer 72: 1192–1198

    Article  PubMed  CAS  Google Scholar 

  • Arriagada R, Le Chevalier Th, Baldeyrou P, Pico JL, Ruffle P, Martin M, El Bakry HM, Duroux P, Bignon J, Lenfant B, Hayat M, Rouesse JG, Sancho-Garnier H, Tubiana M (1985) Alternating radiotherapy and chemotherapy schedules in small cell lung cancer, limited disease. Int J Radiat Oncol Biol Phys 11: 1461–1467

    Article  PubMed  CAS  Google Scholar 

  • Arriagada R, Le Chevalier Th, Pignon JP et al. (1993) Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer. N Engl J Med 329: 1848–1852

    Article  PubMed  CAS  Google Scholar 

  • Arriagada R, Le Chevalier Th, Borie F, Rivière A, Chomy P, Monnet I, Tardivon A, Viader F, Tarayre M, Benhamou S (1995) Prophylactic cranial irradiation for patients with small cell lung cancer in complete remission. J Natl Cancer Inst 87: 183–190

    Article  PubMed  CAS  Google Scholar 

  • Braun MM, Caporaso NE, Page WF, Hoover RN (1994) Genetic component of lung cancer: cohort study of twins. Lancet 344: 440–443

    Article  PubMed  CAS  Google Scholar 

  • Brennan J, O’Connor T, Makuch RW et al. (1991) Myc family DNA amplification in 107 tumors and tumor cell lines from patients with small cell lung cancer treated with different combination chemotherapy regimens. Cancer Res 51: 1708–1712

    PubMed  CAS  Google Scholar 

  • Brock J, Niederle N (1989) Spätkomplikationen am Gehirn nach adjuvanter ZNSTherapie. MMW 131: 901–904

    Google Scholar 

  • Brugger W, Birken R, Bertz H et al. (1993) Peripheral blood progenitor cells mobilized by chemotherapy + G-CSF accelerate both neutrophil and platelet recovery after high dose VP 16, ifosfamide and cisplatin. Br J Haematol 84: 402

    Article  PubMed  CAS  Google Scholar 

  • Bunn PA Jr., Van Zandwijk N, Pastorino U et al. (1994) First Euro-American forum on lung cancer treatment. Eur J Cancer 30A: 710–713

    Article  Google Scholar 

  • Choi NC, Carey RW (1989) Importance of radiation dose in achieving improved loco-regional tumor control in limited stage small cell lung carcinoma: An update. Int J Radiat Oncol Biol Phys 17: 307–310

    Google Scholar 

  • Cox JD, Byhardt R, Komaki R, Wilson JF, Libnoch JA, Hansen R (1979) Interaction of thoracic irradiation and chemotherapy on local control and survival in small cell carcinoma of the lung. Cancer Treat Rep 63: 1251–1255

    PubMed  CAS  Google Scholar 

  • Clark PI, Cottier B (1992) The activity of 10-,14-, and 21-day schedules of single agent etoposide in previously untreated patients with extensive small cell lung cancer. Semin Oncol 19 Suppl. 141: 36–39

    Google Scholar 

  • Cluitmans FHM, Meinders AE (1990) Management of severe hyponatremia. Rapid or slow correction? Am J Med 88: 161–166

    Article  PubMed  CAS  Google Scholar 

  • Eberhardt W, Seeber S, Niederle N (1993) CEV–ein wirksames Regime zur Therapie von Patienten mit fortgeschrittenen kleinzelligen Bronchialkarzinomen. In: Hellriegel KP, Seeber S (Hrsg). Neue Aspekte für die Chemotherapie von Malignomen. Zuckschwerdt, München Bern Wien New York (Aktuelle Onkologie, Bd 70, S 1–7 )

    Google Scholar 

  • Ettinger DS, Finkelstein DM, Abeloff MD, Ruckdeschel JC, Aisner SC, Eglleston JC (1990) A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small-cell lung cancer: A phase III study of the Eastern Cooperative Oncology Group. J Clin Oncol 8: 230–240

    Google Scholar 

  • Fleck JF, Einhorn LH, Lauer RC, Schultz SM, Miller ME (1990) Is prophylactic cranial irradiation indicated in small-cell lung cancer? J Clin Oncol 8: 209–214

    PubMed  CAS  Google Scholar 

  • Fujiwara T, Grimm EA, Mukhopadhyay T, Zhang WW, Owen-Schaub LB, Roth JA (1994) Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res 54: 2287–2291

    PubMed  CAS  Google Scholar 

  • Gatzemeier U (1989) Therapie mit Epirubicin wöchentlich bei älteren Patienten mit kleinzelligem Bronchialkarzinom. In: Scheulen ME, Niederle N (Hrsg). Wöchentlich fraktioniertes Epirubicin. Klinische Pharmakologie und Indikationen. Zuckschwerdt, München Bern Wien San Francisco, ( Aktuelle Onkologie, Bd 52, S 63–69 )

    Google Scholar 

  • Giaccone G, Dalesio O, McVie GJ et al. for the EORTC Lung Cancer Cooperative Group (1993) Maintenance chemotherapy in small-cell lung cancer: long-term results of a randomized trial. J Clin Oncol 11: 1230–1240

    Google Scholar 

  • Gschwantler M, Weiss W (1994) Hyponatriämisches Koma als Erstsymptom eines kleinzelligen Bronchialkarzinoms. Dtsch Med Wochenschr 119: 261–264

    Article  PubMed  CAS  Google Scholar 

  • Hara N, Ohta M, Ichinose Y, Motohiro A, Kuda T, Asoh H, Kawasaki M (1991) Influence of surgical resection before and after chemotherapy on survival in small cell lung cancer. J Surg Oncol 47: 53–61

    Article  PubMed  CAS  Google Scholar 

  • Harbour JW, Lai SL, Whang-Peng J, Gazdar AF, Mina JD, Kaye FJ (1988) Abnormalities in structure and expression of the human retinoblastoma gene in small cell lung cancer. Science 241: 353–357

    Article  PubMed  CAS  Google Scholar 

  • Hennerici M, Toyka KV (1990) Paraneoplastische Syndrome am Nervensystem. Internist 31: 499–504

    PubMed  CAS  Google Scholar 

  • Hirsch FR, Matthews MJ, Aisner R et al. (1988) Histopathologic classification of small cell lung cancer. Changing concepts and terminology. Cancer 62: 973–977

    Google Scholar 

  • Humblet Y, Symann M, Bosly A et al. (1987) Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study. J Clin Oncol 5: 1864–1873

    PubMed  CAS  Google Scholar 

  • Ihde DC (1992) Chemotherapy of lung cancer. N Engl J Med 327: 1434–1441

    Article  PubMed  CAS  Google Scholar 

  • Jedrychowski W, Becher H, Wahrendorf J, Basa-Cierpialek Z, Gomola K (1992) Effect of tobacco smoking on various histological types of lung cancer. J Cancer Res Clin Oncol 118: 276–282

    Article  PubMed  CAS  Google Scholar 

  • Johnson DH, Turrisi AT, Chang AY, Blum R, Bonomi P, Ettinger D, Wagner H (1993) Alternating chemotherapy and twice-daily thoracic radiotherapy in limited-stage small-cell lung cancer: a pilot study of the Eastern Cooperative Oncology Group. J Clin Oncol 11: 879–884

    PubMed  CAS  Google Scholar 

  • Kessinger A, Armitage JO (1991) The evolving role of autologous peripheral stem cell transplantation following high dose chemotherapy for malignancies. Blood 77: 211

    PubMed  CAS  Google Scholar 

  • Klasa RJ, Murray N, Coldman AJ (1991) Dose-intensity meta-analysis of chemotherapy regimens in small-cell carcinoma of the lung. J Clin Oncol 9: 499–508

    PubMed  CAS  Google Scholar 

  • Lazarus HM (1993) Autologous bone marrow transplantation for the treatment of lung cancer. Semin Oncol 20: 72–79

    PubMed  CAS  Google Scholar 

  • Liengswangwong V, Bonner JA, Shaw EG et al. (1994) Limited-stage small-cell lung cancer: patterns of intrathoracic recurrence and the implications for radiotherapy. J Clin Oncol 12: 496–502

    PubMed  CAS  Google Scholar 

  • Livingston RB, Mira JG, Chen TT, McGavran M, Costanzi JJ, Samson M (1984) Combined modality treatment of extensive small cell lung cancer: A Southwest Oncology Group study. J Clin Oncol 2: 585–590

    Google Scholar 

  • Lorenz J (1994) Neue zellbiologische Erkenntnisse zur Entstehung des Bronchialkarzonoms. Internist 35: 692–699

    PubMed  CAS  Google Scholar 

  • Lowenbraun S, Bartolucci A, Smalley RV, Lynn M, Krauss S, Durant JR (1976) The superiority of combination chemotherapy over single agent chemotherapy in small cell lung carcinoma. Cancer 38: 2208–2216

    Article  Google Scholar 

  • Maksymiuk AW, Jett JR, Earle JD et al. (1994) Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: results of a North Central Cancer Treatment Group randomized clinical trial. J Clin Oncol 12: 70–76

    PubMed  CAS  Google Scholar 

  • Mattson K, Niiranen A, Pyrhanen A, Holsti LR, Kumpulainen E, Cantell K (1992) Natural interferon alfa as maintenance therapy for small cell lung cancer. Eur J Cancer 28A: 1387–1391

    Article  Google Scholar 

  • McCracken JD, Janaki LM, Crowley JJ et al. (1990) Concurrent chemotherapy/ radiotherapy for limited small cell lung carcinoma: A Southwest Oncology Group study. J Clin Oncol 8: 892–898

    Google Scholar 

  • Merlo A, Gabrielson E, Mabry M, Vollmer R, Baylin SB, Sudransky D (1994) Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer. Cancer Res 54: 2322–2326

    PubMed  CAS  Google Scholar 

  • Merkle N, Mikisch G, Kayser K, Drings P, Vogt-Moykopf I (1986) Surgical resection and adjuvant chemotherapy for small cell carcinoma. Thorac Cardiovasc Surg 34: 39–42

    Article  PubMed  CAS  Google Scholar 

  • Meyers CA, Byrne KS, Komaki R (1995) Cognitive deficits in patients with small cell lung cancer before and after chemotherapy. Lung Cancer 12: 231–235

    Article  PubMed  CAS  Google Scholar 

  • Miles DW, Fogarty O, Ash CM et al. (1994) Received dose-intensity: A randomized trial of weekly chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer. J Clin Oncol 12: 77–82

    Google Scholar 

  • Monnet I, Chariot P, Quoix E et al. (1992) Extensive small-cell lung cancer. A randomized comparison of two chemotherapy programs with early crossover in instances of failure. Ann Oncol 3: 813–817

    Google Scholar 

  • Morgan DAL, McGivern D, Fletcher J (1985) Vincristine and etoposide chemotherapy for advanced small cell lung cancer. 3rd Europ Conf Clin Oncol, Stockholm, Abstr 369

    Google Scholar 

  • Müller OA, v. Werder K (1990) Paraneoplastische Endokrinopathien. Internist 31: 492–498

    Google Scholar 

  • Murray N, Coy P, Pater JI et al. (1993) Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. J Clin Oncol 11: 336–344

    PubMed  CAS  Google Scholar 

  • Myklebust AT, Godal A, Pharo A, Juell S, Fodstad 0 (1993) Eradication of small cell lung cancer cells from human bone marrow with immunotoxins. Cancer Res 53: 3784–3788

    CAS  Google Scholar 

  • Nakhosteen JA, Niederle N (1983) Small cell lung cancer: Serial bronchofiberscopy and photographic documentation - the bridge sign. Chest 83: 12–16

    Google Scholar 

  • Niederle N, Schütte J (1985) Chemotherapeutic results in small cell lung cancer. In: Seeber S (Hrsg) Small cell lung cancer. Springer, Berlin Heidelberg New York Tokyo, S 127–145

    Chapter  Google Scholar 

  • Niederle N, Krischke W, Schulz U, Schmidt CG, Seeber S (1982) Untersuchungen zur kurzzeitigen Induktions-and zyklischen Erhaltungstherapie beim inoperablen kleinzelligen Bronchialkarzinom. Klin Wochenschr 60: 829–838

    Article  PubMed  CAS  Google Scholar 

  • Niederle N, Schütte J, Schmidt CG, Seeber S (1984) Treatment of recurrent small cell lung carcinoma with vindesine and cisplatin. Cancer Treat Rep 68: 791–792

    PubMed  CAS  Google Scholar 

  • Niederle N, Schütte J, Seeber S, Schmidt CG (1985) Erste Ergebnisse einer alternierenden Kombinationschemotherapie unter Einschluß von Epirubicin, Cyclophosphamid und Vincristin (EPICO) im Vergleich zum ACO-Protokoll beim kleinzelligen Bronchialkarzinom. In: Nagel GA, Wannenmacher M (Hrsg) Farmorubicin–klinische Erfahrungen. Zuckschwerdt, München Bern Wien (Aktuelle Onkologie, Bd 15, S 133–140 )

    Google Scholar 

  • Niederle N, Eberhardt W, Hirche H (1988) Prätherapeutische prognostische Faktoren beim kleinzelligen Bronchialkarzinom. Oncologie 11 [Suppl 2]: 4348

    Google Scholar 

  • Ohnoshi T, Hiraki S, Ueda N, Fujii M, Machida K, Ueoka H, Yonei T, Kiura K, Kamei H, Segawa Y (1993) Long-term results of combination chemotherapy with or without irradiation in small cell lung cancer: A 5- to 11-year follow-up. Intern Med 32: 215–220

    Article  PubMed  CAS  Google Scholar 

  • Paccagnella A, Favaretto A, Riccardi et al. (1993) Granulocyte-macrophage colony-stimulating factor increases dose intesity of chemotherapy in small cell lung cancer. Cancer 72: 697–706

    Article  PubMed  CAS  Google Scholar 

  • Pignon JP, Arriagada R, Ihde DC et al. (1992) A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 327: 1618–1624

    Article  PubMed  CAS  Google Scholar 

  • Radice PA, Matthews MJ, Ihde DC et al. (1982) The clinical behaviour of „mixed“ small cell/large cell bronchogenic carcinoma compared to „pure” small cell subtypes. Cancer 50: 2894–2902

    Article  PubMed  CAS  Google Scholar 

  • Roth BJ, Johnson DH, Einhorn LH et al. (1992) Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: A Phase III trial of the Southwestern Cancer Study Group. J Clin Oncol 10: 282291

    Google Scholar 

  • Sause WT (1992) Prophylactic cranial irradiation: advantages and disadvantages. Ann Oncol 3 [Suppl 3]:S 51-S 55

    Google Scholar 

  • Schirren J, Krysa S, Bülzebruck H, Horn M, Branscheid D, Drings P (1991) Das kleinzellige Bronchialkarzinom - eine Operationsindikation? Z Herz-, Thorax-, Gefäßchir 5: 260–266

    Google Scholar 

  • Schnipper LE (1986) Clinical implications of tumor-cell heterogeneity. N Engl J Med 314: 1423–1431

    Article  PubMed  CAS  Google Scholar 

  • Schütte J, Niederle N, Doberauer C, Seeber S, Stuschke M, Bamberg M (1988) CCNU, etoposide and methotrexate ( CEM) plus/minus radiotherapy - a low toxicity induction therapy for small cell lung cancer patients with cardiac disease, advanced age or poor performance status. Tumor Diagnostik Therapie 9: 77–81

    Google Scholar 

  • Schütte J, Niederle N, Eberhardt Wet al. (1989) Sequentielle Induktionschemotherapie and Strahlenbehandlung inoperabler kleinzelliger Bronchialkarzinome. Kiin Wochenschr 67: 1182–1193

    Article  Google Scholar 

  • Seeber S, Niederle N, Schilcher RB, Schmidt CG (1980) Adriamycin, Cyclophosphamid and Vincristin (ACO) beim kleinzelligen Bronchialkarzinom. Verlaufsanalyse and Langzeitergebnisse. Onkologie 3: 5–11

    Google Scholar 

  • Shepherd FA, Evans WK, Feld R, Young V, Patterson GA, Ginsberg R, Johansen E (1988) Adjuvant chemotherapy following surgical resection for small cell carcinoma of the lung. J Clin Oncol 6: 832–838

    PubMed  CAS  Google Scholar 

  • Shepherd SA, Ginsberg RJ, Feld R, Evans WK, Johansen E (1991) Surgical treatment for limited small-cell lung cancer: The University of Toronto Lung Oncology Group experience. J Thorac Cardiovasc Surg 101: 385–393

    Google Scholar 

  • Shepherd FA, Ginsberg RJ, Haddad R et al. (1993) Importance of clinical staging in limited small-cell lung cancer: A valuable system to separate prognostic subgroups. J Clin Oncol 8: 1592–1597

    Google Scholar 

  • Shields TW, Higgins GA, Matthews MJ, Keehn RJ (1982) Surgical resection in the management of small cell carcinoma of the lung. J Thorac Cardiovasc Surg 84: 481–488

    PubMed  CAS  Google Scholar 

  • Skarlos DV, Samantas E, Kosmidis P et al. (1994) Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer. Ann Oncol 5: 601–607

    PubMed  CAS  Google Scholar 

  • Skov BG, Hirsch FR, Bobrow L (1992) Monoclonal antibodies in the detection of bone marrow metastases in small cell lung cancer. Br J Cancer 65: 593–596

    Article  PubMed  CAS  Google Scholar 

  • Slevin ML, Clark PI, Joel SP et al. (1989) A randomized trial to evaluate the effect of schedule on the activity of etoposide. J Clin Oncol 7: 1333–1340

    PubMed  CAS  Google Scholar 

  • Slevin ML, Joel SP (1993) Prolonged oral etoposide in small cell lung cancer. Ann Oncol 4: 529–532

    PubMed  CAS  Google Scholar 

  • Smith IE, Harland SJ, Robinson BA et al. (1985) Carboplatin: A very active new cisplatin analog in the treatment of small cell lung cancer. Cancer Treat Rep 69: 43–46

    Google Scholar 

  • Souhami RL, Rudd R, Ruiz de Elvira MC et al. (1994) Randomized trial comparing weekly versus 3-week chemotherapy in small-cell lung cancer: A cancer research campaign trial. J Clin Oncol 12: 1806–1813

    Google Scholar 

  • Spiegelman D, Maurer LH, Ware JH et al. (1989) Prognostic factors in small-cell carcinoma of the lung: An analysis of 1521 patients. J Clin Oncol 7: 344–354

    PubMed  CAS  Google Scholar 

  • Wandl UB, Niederle N (1992) The concept of dose intensification in the treatment of neoplastic disease. Infection 20 [Suppl 21: S 107-S 110

    Google Scholar 

  • Warde P, Payne D (1992) Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 10: 890–895

    PubMed  CAS  Google Scholar 

  • Wilke H, Achterrath W, Schmoll HJ, Gunzer U, Preusser P, Lenaz L (1988) Etoposide and split-course Cisplatin in small-cell lung cancer. Am J Clin Oncol 11: 572–578

    Article  PubMed  CAS  Google Scholar 

  • Wolf M, Pritsch M, Drings P et al. (1991) Cyclic-alternating versus response-oriented chemotherapy in small-cell lung cancer. A German multicenter randomized trial of 321 patients. J Clin Oncol 9: 614–624

    PubMed  CAS  Google Scholar 

  • World Health Organization (1982) The World Health Organization histological typing of lung tumors, 2nd ed. Am J Clin Pathol 77:123–136

    Google Scholar 

Download references

Authors
  1. N. Niederle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Weidmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V. Budach
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Schirren
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik, Innere Medizin IV, Abteilung Hämatologie/Onkologie, Martin-Luther-Universität Halle-Wittenberg, Ernst-Grube-Straße 40, D-06120, Halle/Saale, Deutschland

    Hans-Joachim Schmoll (Direktor) (Direktor)

  2. Klinik und Poliklinik für Innere Medizin II, Klinikum der Friedrich-Schiller-Universität Jena, Erlanger Allee 101, D-07740, Jena, Deutschland

    Klaus Höffken (Direktor) (Direktor)

  3. Medizinischen Klinik II, Schwerpunkt Onkologie und Hämatologie, Humboldt-Universität, Universitätsklinikum Charité, Schumannstraße 20/21, D-10117, Berlin, Deutschland

    Kurt Possinger (Direktor) (Direktor)

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Niederle, N., Weidmann, B., Budach, V., Schirren, J. (1997). Kleinzelliges Bronchialkarzinom. In: Schmoll, HJ., Höffken, K., Possinger, K. (eds) Kompendium Internistische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-12175-7_27

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-12175-7_27

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-60830-1

  • Online ISBN: 978-3-662-12175-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation